These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 16386961

  • 1. Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.
    Piriou ER, van Dort K, Weel JF, Bemelman FJ, Gamadia LE, van Oers MH, van Baarle D.
    Clin Immunol; 2006 Apr; 119(1):16-20. PubMed ID: 16386961
    [Abstract] [Full Text] [Related]

  • 2. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
    Piriou ER, van Dort K, Nanlohy NM, van Oers MH, Miedema F, van Baarle D.
    Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243
    [Abstract] [Full Text] [Related]

  • 3. A11 Tetramer-assisted characterization of Rta-specific CD8+ T-cell responses in healthy virus carriers.
    Yu HX, Srinivasan N, Ren EE, Chan SH.
    Tissue Antigens; 2005 Jun; 65(6):539-43. PubMed ID: 15896201
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N, Kimura H, Hara S, Hoshino Y, Kojima S, Morishima T, Tsurumi T, Kuzushima K.
    J Infect Dis; 2004 Sep 01; 190(5):985-8. PubMed ID: 15295706
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
    Meij P, Bloemena E, Palmen N, Brink A, Vervoort MB, Meijer CJ, Middeldorp JM.
    Cell Immunol; 2001 Feb 25; 208(1):25-33. PubMed ID: 11277616
    [Abstract] [Full Text] [Related]

  • 9. Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection.
    Hoshino Y, Morishima T, Kimura H, Nishikawa K, Tsurumi T, Kuzushima K.
    J Immunol; 1999 Nov 15; 163(10):5735-40. PubMed ID: 10553106
    [Abstract] [Full Text] [Related]

  • 10. Differential targeting and shifts in the immunodominance of Epstein-Barr virus--specific CD8 and CD4 T cell responses during acute and persistent infection.
    Woodberry T, Suscovich TJ, Henry LM, Davis JK, Frahm N, Walker BD, Scadden DT, Wang F, Brander C.
    J Infect Dis; 2005 Nov 01; 192(9):1513-24. PubMed ID: 16206065
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ, McAulay KA, Anthony IC, Crawford DH.
    J Med Virol; 2009 May 01; 81(5):870-7. PubMed ID: 19319950
    [Abstract] [Full Text] [Related]

  • 13. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
    Hammer MH, Brestrich G, Mittenzweig A, Roemhild A, Zwinger S, Subklewe M, Beier C, Kurtz A, Babel N, Volk HD, Reinke P.
    J Immunother; 2007 May 01; 30(8):817-24. PubMed ID: 18049333
    [Abstract] [Full Text] [Related]

  • 14. Properties of CD4(+) T cells in human cytomegalovirus infection.
    Gamadia LE, Rentenaar RJ, van Lier RA, ten Berge IJ.
    Hum Immunol; 2004 May 01; 65(5):486-92. PubMed ID: 15172448
    [Abstract] [Full Text] [Related]

  • 15. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
    Cameron B, Bharadwaj M, Burrows J, Fazou C, Wakefield D, Hickie I, Ffrench R, Khanna R, Lloyd A, Dubbo Infection Outcomes Study.
    J Infect Dis; 2006 Mar 01; 193(5):664-71. PubMed ID: 16453261
    [Abstract] [Full Text] [Related]

  • 16. Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection.
    Precopio ML, Sullivan JL, Willard C, Somasundaran M, Luzuriaga K.
    J Immunol; 2003 Mar 01; 170(5):2590-8. PubMed ID: 12594286
    [Abstract] [Full Text] [Related]

  • 17. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G, Hamidou MA, Clémenceau B, Gaschet J, Tiberghien P, Ferrand C, Vivien R, Barbarot S, Coste-Burel M, Moreau A, Vié H.
    Clin Immunol; 2006 Apr 01; 119(1):79-86. PubMed ID: 16386957
    [Abstract] [Full Text] [Related]

  • 18. Identification of CD8+ T-cell epitopes specific for immediate-early transactivator Rta of Epstein-Barr virus.
    Yu H, Srinivasan N, Ren E, Chan S.
    Hum Immunol; 2005 May 01; 66(5):483-93. PubMed ID: 15935885
    [Abstract] [Full Text] [Related]

  • 19. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
    Benninger-Döring G, Pepperl S, Deml L, Modrow S, Wolf H, Jilg W.
    Virology; 1999 Nov 25; 264(2):289-97. PubMed ID: 10562493
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.
    Clave E, Agbalika F, Bajzik V, Peffault de Latour R, Trillard M, Rabian C, Scieux C, Devergie A, Socié G, Ribaud P, Adès L, Ferry C, Gluckman E, Charron D, Esperou H, Toubert A, Moins-Teisserenc H.
    Transplantation; 2004 Jan 15; 77(1):76-84. PubMed ID: 14724439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.